Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nicolas Alan Menzies, Ph.D.

Title
Institution
Department
Address
Phone
Profile Picture

Overview
Nick Menzies is Associate Professor of Global Health in the Department of Global Health and Population, and part of the core faculty of the Harvard Center for Health Decision Science. Professor Menzies uses decision science and quantitative research to understand the consequences of policies to combat major infectious diseases, and help design effective disease control programs when resources are limited.

Research

Professor Menzies combines empirical data with mathematical modeling to examine infectious disease control policy in high burden settings, currently focusing on the intersection of HIV and TB epidemics in sub-saharan Africa and other high-burden settings.

In his empirical research Nick has worked to improved the level of evidence on the resource requirements for HIV interventions in high burden settings, allowing for better budgeting of these large programs and allowing decision-makers to weigh the advantages of different implementation approaches. Nick is currently working on a multi-country study to understand the costs, cost drivers and efficiency determinants of routine immunization services. Other applied work has addressed the costs and benefits of expanding access to HIV screening and diagnosis in high prevalence settings.

The long-term population-level impacts of disease control policy are often difficult to assess empirically, especially for infectious diseases. Yet these are often the outcomes of interest when planning major public health investments. Through a number of studies Nick has used mathematical modelling - computer experiments which seek to recreate the underlying mechanisms generating health outcomes and resource utilization - to compare competing policy options being considered by HIV or TB control programs and directly inform the policy debate.

Professor Menzies's methodological interests include Bayesian approaches to calibrating simulation models, value of information analysis, the use of simulation models for causal inference, and approaches for synthesizing results from multiple models to inform policy.

Prior to joining Harvard Nick worked with the Global AIDS Program at the U.S. Centers for Disease Control and Prevention, conducting economic evaluation and implementation research on HIV/AIDS control interventions in countries supported by the President's Emergency Plan for AIDS Relief (PEPFAR).

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01AI146555 (MENZIES, NICOLAS A) Dec 5, 2019 - Nov 30, 2024
    NIH
    Optimal targeting for individual and population-level TB prevention
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Earnest R, Rönn MM, Bellerose M, Menon-Johansson AS, Berruti AA, Chesson HW, Gift TL, Hsu KK, Testa C, Zhu L, Malyuta Y, Menzies NA, Salomon JA. Modeling the Cost-Effectiveness of Express Multisite Gonorrhea Screening Among Men Who Have Sex With Men in the United States. Sex Transm Dis. 2021 Nov 01; 48(11):805-812. PMID: 33993161.
    Citations:    Fields:    
  2. Pitzer VE, Chitwood M, Havumaki J, Menzies NA, Perniciaro S, Warren JL, Weinberger DM, Cohen T. The Impact of Changes in Diagnostic Testing Practices on Estimates of COVID-19 Transmission in the United States. Am J Epidemiol. 2021 09 01; 190(9):1908-1917. PMID: 33831148.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  3. McQuaid CF, Clarkson MC, Bellerose M, Floyd K, White RG, Menzies NA. An approach for improving the quality of country-level TB modelling. Int J Tuberc Lung Dis. 2021 08 01; 25(8):614-619. PMID: 34330345.
    Citations:    Fields:    Translation:Humans
  4. Kim S, Cohen T, Horsburgh CR, Miller JW, Hill AN, Marks SM, Li R, Kammerer JS, Salomon JA, Menzies NA. Trends, mechanisms, and racial/ethnic differences of tuberculosis incidence in the US-born population aged 50 years or older in the United States. Clin Infect Dis. 2021 Jul 29. PMID: 34323959.
    Citations:    Fields:    
  5. Chitwood MH, Russi M, Gunasekera K, Havumaki J, Klaassen F, Pitzer VE, Salomon JA, Swartwood NA, Warren JL, Weinberger DM, Cohen T, Menzies NA. Reconstructing the course of the COVID-19 epidemic over 2020 for US states and counties: results of a Bayesian evidence synthesis model. medRxiv. 2021 Jul 22. PMID: 33851183.
    Citations:    
  6. Clarke-Deelder E, Suharlim C, Chatterjee S, Brenzel L, Ray A, Cohen JL, McConnell M, Resch SC, Menzies NA. Impact of campaign-style delivery of routine vaccines: a quasi-experimental evaluation using routine health services data in India. Health Policy Plan. 2021 May 17; 36(4):454-463. PMID: 33734362.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  7. Yang C, Kang J, Lu L, Guo X, Shen X, Cohen T, Menzies NA. The positive externalities of migrant-based TB control strategy in a Chinese urban population with internal migration: a transmission-dynamic modeling study. BMC Med. 2021 04 20; 19(1):95. PMID: 33874940.
    Citations:    Fields:    
  8. Chitwood MH, Pelissari DM, Marques da Silva GD, Bartholomay P, Rocha MS, Arakaki-Sanchez D, Sanchez M, Cohen T, Castro MC, Menzies NA. Trends in Untreated Tuberculosis in Large Municipalities, Brazil, 2008-2017. Emerg Infect Dis. 2021 03; 27(3):957-960. PMID: 33622464.
    Citations:    Fields:    Translation:Humans
  9. Cates L, Crudu V, Codreanu A, Ciobanu N, Fosburgh H, Cohen T, Menzies NA. Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting. Int J Tuberc Lung Dis. 2021 03 01; 25(3):228-230. PMID: 33688812.
    Citations: 1     Fields:    Translation:HumansCells
  10. Sohn H, Sweeney S, Mudzengi D, Creswell J, Menzies NA, Fox GJ, MacPherson P, Dowdy DW. Determining the value of TB active case-finding: current evidence and methodological considerations. Int J Tuberc Lung Dis. 2021 03 01; 25(3):171-181. PMID: 33688805.
    Citations: 1     Fields:    Translation:Humans
  11. Chitwood MH, Pelissari DM, Drummond Marques da Silva G, Bartholomay P, Rocha MS, Sanchez M, Arakaki-Sanchez D, Glaziou P, Cohen T, Castro MC, Menzies NA. Bayesian evidence synthesis to estimate subnational TB incidence: An application in Brazil. Epidemics. 2021 Jun; 35:100443. PMID: 33676092.
    Citations:    Fields:    
  12. James LP, Salomon JA, Buckee CO, Menzies NA. The Use and Misuse of Mathematical Modeling for Infectious Disease Policymaking: Lessons for the COVID-19 Pandemic. Med Decis Making. 2021 05; 41(4):379-385. PMID: 33535889.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  13. Yaesoubi R, Havumaki J, Chitwood MH, Menzies NA, Gonsalves G, Salomon JA, Paltiel AD, Cohen T. Adaptive Policies to Balance Health Benefits and Economic Costs of Physical Distancing Interventions during the COVID-19 Pandemic. Med Decis Making. 2021 05; 41(4):386-392. PMID: 33504258.
    Citations:    Fields:    Translation:HumansPHPublic Health
  14. Greene SK, McGough SF, Culp GM, Graf LE, Lipsitch M, Menzies NA, Kahn R. Nowcasting for Real-Time COVID-19 Tracking in New York City: An Evaluation Using Reportable Disease Data From Early in the Pandemic. JMIR Public Health Surveill. 2021 01 15; 7(1):e25538. PMID: 33406053.
    Citations: 1     Translation:HumansPHPublic Health
  15. Menzies NA, Swartwood N, Testa C, Malyuta Y, Hill AN, Marks SM, Cohen T, Salomon JA. Time Since Infection and Risks of Future Disease for Individuals with Mycobacterium tuberculosis Infection in the United States. Epidemiology. 2021 01; 32(1):70-78. PMID: 33009253.
    Citations: 1     Fields:    Translation:HumansCells
  16. Hsieh YL, Jahn A, Menzies NA, Yaesoubi R, Salomon JA, Girma B, Gunde L, Eaton JW, Auld A, Odo M, Kiyiika CN, Kalua T, Chiwandira B, Mpunga JU, Mbendra K, Corbett L, Hosseinipour MC, Cohen T, Kunkel A. Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi. J Acquir Immune Defic Syndr. 2020 12 15; 85(5):643-650. PMID: 33177475.
    Citations: 1     Fields:    Translation:Humans
  17. Tuite AR, Testa C, Rönn M, Bellerose M, Gift T, Fridge J, Molotnikov L, Desmarais C, Berruti A, Menzies N, Malyuta Y, Hsu K, Salomon JA. Exploring How Epidemic Context Influences Syphilis Screening Impact: A Mathematical Modeling Study. Sex Transm Dis. 2020 12; 47(12):798-810. PMID: 32976353.
    Citations:    Fields:    Translation:HumansPHPublic Health
  18. Menzies NA, Bellerose M, Testa C, Swartwood NA, Malyuta Y, Cohen T, Marks SM, Hill AN, Date AA, Maloney SA, Bowden SE, Grills AW, Salomon JA. Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States. Am J Respir Crit Care Med. 2020 12 01; 202(11):1567-1575. PMID: 32645277.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  19. Shrestha S, Parriott A, Menzies NA, Shete PB, Hill AN, Marks SM, Dowdy DW. Estimated Population-Level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United States. Ann Am Thorac Soc. 2020 12; 17(12):1639-1642. PMID: 32916062.
    Citations:    Fields:    Translation:Humans
  20. Hill AN, Cohen T, Salomon JA, Menzies NA. High-resolution estimates of tuberculosis incidence among non-U.S.-born persons residing in the United States, 2000-2016. Epidemics. 2020 12; 33:100419. PMID: 33242759.
    Citations:    Fields:    Translation:HumansPHPublic Health
  21. Portnoy A, Resch SC, Suharlim C, Brenzel L, Menzies NA. What We Do Not Know About the Costs of Immunization Programs in Low- and Middle-Income Countries. Value Health. 2021 01; 24(1):67-69. PMID: 33431155.
    Citations:    Fields:    Translation:Humans
  22. Greene SK, McGough SF, Culp GM, Graf LE, Lipsitch M, Menzies NA, Kahn R. Evaluation of Nowcasting for Real-Time COVID-19 Tracking - New York City, March-May 2020. medRxiv. 2020 Oct 20. PMID: 33106814.
    Citations:    
  23. Gomez GB, Mudzengi DL, Bozzani F, Menzies NA, Vassall A. Estimating Cost Functions for Resource Allocation Using Transmission Models: A Case Study of Tuberculosis Case Finding in South Africa. Value Health. 2020 12; 23(12):1606-1612. PMID: 33248516.
    Citations: 1     Fields:    Translation:Humans
  24. Hsieh YL, Jahn A, Menzies NA, Yaesoubi R, Salomon JA, Girma B, Gunde L, Eaton JW, Auld A, Odo M, Kiyiika CN, Kalua T, Chiwandira B, Mpunga JU, Mbendra K, Corbett L, Hosseinipour MC, Cohen T, Kunkel A. An evaluation of 6-month versus continuous isoniazid preventive therapy for M. tuberculosis in adults living with HIV/AIDS in Malawi. . 2020 Sep 09. PMID: 32925361.
    Citations:    
  25. Kalichman SC, Shkembi B, Wanyenze RK, Naigino R, Bateganya MH, Menzies NA, Lin CD, Lule H, Kiene SM. Perceived HIV stigma and HIV testing among men and women in rural Uganda: a population-based study. Lancet HIV. 2020 12; 7(12):e817-e824. PMID: 32910903.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  26. Rönn MM, Dunville R, Wang LY, Bellerose M, Malyuta Y, Menzies NA, Aslam M, Lewis F, Walker-Baban C, Asbel L, Parchem S, Masinter L, Perez E, Gift TL, Hsu K, Barrios LC, Salomon JA. Mathematical modeling study of school-based chlamydia screening: potential impact on chlamydia prevalence in intervention schools and surrounding communities. BMC Public Health. 2020 Sep 05; 20(1):1363. PMID: 32891137.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  27. Marx FM, Cohen T, Menzies NA, Salomon JA, Theron G, Yaesoubi R. Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis. Lancet Glob Health. 2020 09; 8(9):e1223-e1233. PMID: 32827484.
    Citations:    Fields:    Translation:HumansPHPublic Health
  28. Portnoy A, Vaughan K, Clarke-Deelder E, Suharlim C, Resch SC, Brenzel L, Menzies NA. Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates. Pharmacoeconomics. 2020 09; 38(9):995-1005. PMID: 32596785.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  29. Earnest R, Rönn MM, Bellerose M, Gift TL, Berruti AA, Hsu KK, Testa C, Zhu L, Malyuta Y, Menzies NA, Salomon JA. Population-level Benefits of Extragenital Gonorrhea Screening Among Men Who Have Sex With Men: An Exploratory Modeling Analysis. Sex Transm Dis. 2020 07; 47(7):484-490. PMID: 32355108.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  30. Marks SM, Dowdy DW, Menzies NA, Shete PB, Salomon JA, Parriott A, Shrestha S, Flood J, Hill AN. Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination. Public Health Rep. 2020 Jul/Aug; 135(1_suppl):38S-43S. PMID: 32735183.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  31. Kintu A, Sando D, Okello S, Mutungi G, Guwatudde D, Menzies NA, Danaei G, Verguet S. Integrating care for non-communicable diseases into routine HIV services: key considerations for policy design in sub-Saharan Africa. J Int AIDS Soc. 2020 06; 23 Suppl 1:e25508. PMID: 32562370.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  32. Sando D, Kintu A, Okello S, Kawungezi PC, Guwatudde D, Mutungi G, Muyindike W, Menzies NA, Danaei G, Verguet S. Cost-effectiveness analysis of integrating screening and treatment of selected non-communicable diseases into HIV/AIDS treatment in Uganda. J Int AIDS Soc. 2020 06; 23 Suppl 1:e25507. PMID: 32562364.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  33. Yaesoubi R, Havumaki J, Chitwood MH, Menzies NA, Gonsalves G, Salomon J, Paltiel AD, Cohen T. Adaptive policies for use of physical distancing interventions during the COVID-19 pandemic. medRxiv. 2020 Jun 01. PMID: 32577698.
    Citations:    
  34. Kunst N, Wilson ECF, Glynn D, Alarid-Escudero F, Baio G, Brennan A, Fairley M, Goldhaber-Fiebert JD, Jackson C, Jalal H, Menzies NA, Strong M, Thom H, Heath A. Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods. Value Health. 2020 06; 23(6):734-742. PMID: 32540231.
    Citations: 2     Fields:    Translation:Humans
  35. Pitzer VE, Chitwood M, Havumaki J, Menzies NA, Perniciaro S, Warren JL, Weinberger DM, Cohen T. The impact of changes in diagnostic testing practices on estimates of COVID-19 transmission in the United States. medRxiv. 2020 Apr 24. PMID: 32511624.
    Citations:    
  36. Heath A, Kunst N, Jackson C, Strong M, Alarid-Escudero F, Goldhaber-Fiebert JD, Baio G, Menzies NA, Jalal H. Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies. Med Decis Making. 2020 04; 40(3):314-326. PMID: 32297840.
    Citations: 2     Fields:    Translation:Humans
  37. Rönn MM, Menzies NA, Gift TL, Chesson HW, Trikalinos TA, Bellerose M, Malyuta Y, Berruti A, Gaydos CA, Hsu KK, Salomon JA. Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis. Clin Infect Dis. 2020 04 15; 70(9):1816-1823. PMID: 31504314.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  38. Zhu L, Menzies NA, Wang J, Linas BP, Goodreau SM, Salomon JA. Estimation and correction of bias in network simulations based on respondent-driven sampling data. Sci Rep. 2020 04 14; 10(1):6348. PMID: 32286412.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  39. McGough SF, Johansson MA, Lipsitch M, Menzies NA. Nowcasting by Bayesian Smoothing: A flexible, generalizable model for real-time epidemic tracking. PLoS Comput Biol. 2020 04; 16(4):e1007735. PMID: 32251464.
    Citations: 16     Fields:    Translation:HumansPHPublic Health
  40. Rönn MM, Testa C, Tuite AR, Chesson HW, Gift TL, Schumacher C, Williford SL, Zhu L, Bellerose M, Earnest R, Malyuta Y, Hsu KK, Salomon JA, Menzies NA. The Potential Population-Level Impact of Different Gonorrhea Screening Strategies in Baltimore and San Francisco: An Exploratory Mathematical Modeling Analysis. Sex Transm Dis. 2020 03; 47(3):143-150. PMID: 31842089.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  41. Quaife M, Houben RMGJ, Allwood B, Cohen T, Coussens AK, Harries AD, van Kampen S, Marx FM, Sweeney S, Wallis RS, Menzies NA. Post-tuberculosis mortality and morbidity: valuing the hidden epidemic. Lancet Respir Med. 2020 04; 8(4):332-333. PMID: 32057300.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  42. Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, Marks SM, Hill AN, Winston CA, Asay GR, Barry P, Readhead A, Flood J, Kahn JG, Shete PB. Comparative Modeling of Tuberculosis Epidemiology and Policy Outcomes in California. Am J Respir Crit Care Med. 2020 02 01; 201(3):356-365. PMID: 31626560.
    Citations: 4     Fields:    Translation:Humans
  43. Menzies NA, Suharlim C, Resch SC, Brenzel L. The efficiency of routine infant immunization services in six countries: a comparison of methods. Health Econ Rev. 2020 Jan 08; 10(1):1. PMID: 31916025.
    Citations:    
  44. Munk C, Portnoy A, Suharlim C, Clarke-Deelder E, Brenzel L, Resch SC, Menzies NA. Systematic review of the costs and effectiveness of interventions to increase infant vaccination coverage in low- and middle-income countries. BMC Health Serv Res. 2019 Oct 22; 19(1):741. PMID: 31640687.
    Citations: 8     Fields:    Translation:Humans
  45. Clarke-Deelder E, Vassall A, Menzies NA. Estimators Used in Multisite Healthcare Costing Studies in Low- and Middle-Income Countries: A Systematic Review and Simulation Study. Value Health. 2019 10; 22(10):1146-1153. PMID: 31563257.
    Citations: 8     Fields:    
  46. Trauer JM, Dodd PJ, Gomes MGM, Gomez GB, Houben RMGJ, McBryde ES, Melsew YA, Menzies NA, Arinaminpathy N, Shrestha S, Dowdy DW. The Importance of Heterogeneity to the Epidemiology of Tuberculosis. Clin Infect Dis. 2019 06 18; 69(1):159-166. PMID: 30383204.
    Citations: 13     Fields:    Translation:Humans
  47. Feldhaus I, Schütte C, Mwansa FD, Undi M, Banda S, Suharlim C, Menzies NA, Brenzel L, Resch SC, Kinghorn A. Incorporating costing study results into district and service planning to enhance immunization programme performance: a Zambian case study. Health Policy Plan. 2019 Jun 01; 34(5):327-336. PMID: 31157376.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  48. Isanaka S, Barnhart DA, McDonald CM, Ackatia-Armah RS, Kupka R, Doumbia S, Brown KH, Menzies NA. Cost-effectiveness of community-based screening and treatment of moderate acute malnutrition in Mali. BMJ Glob Health. 2019; 4(2):e001227. PMID: 31139441.
    Citations: 5     
  49. Menzies NA, McQuaid CF, Gomez GB, Siroka A, Glaziou P, Floyd K, White RG, Houben RMGJ. Improving the quality of modelling evidence used for tuberculosis policy evaluation. Int J Tuberc Lung Dis. 2019 04 01; 23(4):387-395. PMID: 31053179.
    Citations: 2     Fields:    Translation:Humans
  50. Rönn MM, Tuite AR, Menzies NA, Wolf EE, Gift TL, Chesson HW, Torrone E, Berruti A, Mazzola E, Galer K, Hsu K, Salomon JA. The Impact of Screening and Partner Notification on Chlamydia Prevalence and Numbers of Infections Averted in the United States, 2000-2015: Evaluation of Epidemiologic Trends Using a Pair-Formation Transmission Model. Am J Epidemiol. 2019 03 01; 188(3):545-554. PMID: 30608525.
    Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
  51. Houben RMGJ, Esmail H, Emery JC, Joslyn LR, McQuaid CF, Menzies NA, Sanz J, Shrestha S, White RG, Yang C, Cobelens F. Spotting the old foe-revisiting the case definition for TB. Lancet Respir Med. 2019 03; 7(3):199-201. PMID: 30823971.
    Citations: 5     Fields:    Translation:HumansCells
  52. Houben RMGJ, Lalli M, Kranzer K, Menzies NA, Schumacher SG, Dowdy DW. What if They Don't Have Tuberculosis? The Consequences and Trade-offs Involved in False-positive Diagnoses of Tuberculosis. Clin Infect Dis. 2019 01 01; 68(1):150-156. PMID: 29982375.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  53. Cudahy PGT, Andrews JR, Bilinski A, Dowdy DW, Mathema B, Menzies NA, Salomon JA, Shrestha S, Cohen T. Spatially targeted screening to reduce tuberculosis transmission in high-incidence settings. Lancet Infect Dis. 2019 03; 19(3):e89-e95. PMID: 30554997.
    Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
  54. Menzies NA, Hill AN, Cohen T, Salomon JA. The impact of migration on tuberculosis in the United States. Int J Tuberc Lung Dis. 2018 12 01; 22(12):1392-1403. PMID: 30606311.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  55. Tuite AR, Rönn MM, Wolf EE, Gift TL, Chesson HW, Berruti A, Galer K, Menzies NA, Hsu K, Salomon JA. Estimated Impact of Screening on Gonorrhea Epidemiology in the United States: Insights From a Mathematical Model. Sex Transm Dis. 2018 11; 45(11):713-722. PMID: 29894368.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  56. Menzies NA, Cohen T, Hill AN, Yaesoubi R, Galer K, Wolf E, Marks SM, Salomon JA. Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model. Am J Epidemiol. 2018 09 01; 187(9):2011-2020. PMID: 29762657.
    Citations: 23     Fields:    Translation:HumansPHPublic Health
  57. Menzies NA, Cohen T, Salomon JA. Evidence sources on the natural history of latent tuberculosis infection. Lancet Infect Dis. 2018 08; 18(8):834-835. PMID: 30064672.
    Citations:    Fields:    Translation:Humans
  58. Chatterjee S, Ghosh A, Das P, Menzies NA, Laxminarayan R. Determinants of cost of routine immunization programme in India. Vaccine. 2018 06 18; 36(26):3836-3841. PMID: 29776749.
    Citations: 3     Fields:    Translation:Humans
  59. Menzies NA, Wolf E, Connors D, Bellerose M, Sbarra AN, Cohen T, Hill AN, Yaesoubi R, Galer K, White PJ, Abubakar I, Salomon JA. Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions. Lancet Infect Dis. 2018 08; 18(8):e228-e238. PMID: 29653698.
    Citations: 16     Fields:    Translation:Humans
  60. Wallis RS, Cohen T, Menzies NA, Churchyard G. Pan-tuberculosis regimens: an argument for. Lancet Respir Med. 2018 04; 6(4):239-240. PMID: 29595501.
    Citations: 5     Fields:    Translation:HumansCells
  61. Marx FM, Yaesoubi R, Menzies NA, Salomon JA, Bilinski A, Beyers N, Cohen T. Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study. Lancet Glob Health. 2018 04; 6(4):e426-e435. PMID: 29472018.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  62. Verguet S, Riumallo-Herl C, Gomez GB, Menzies NA, Houben RMGJ, Sumner T, Lalli M, White RG, Salomon JA, Cohen T, Foster N, Chatterjee S, Sweeney S, Baena IG, Lönnroth K, Weil DE, Vassall A. Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study. Lancet Glob Health. 2017 11; 5(11):e1123-e1132. PMID: 29025634.
    Citations: 14     Fields:    Translation:Humans
  63. Menzies NA, Suharlim C, Geng F, Ward ZJ, Brenzel L, Resch SC. The cost determinants of routine infant immunization services: a meta-regression analysis of six country studies. BMC Med. 2017 10 06; 15(1):178. PMID: 28982358.
    Citations: 6     Fields:    Translation:Humans
  64. Geng F, Suharlim C, Brenzel L, Resch SC, Menzies NA. The cost structure of routine infant immunization services: a systematic analysis of six countries. Health Policy Plan. 2017 Oct 01; 32(8):1174-1184. PMID: 28575193.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  65. Kiene SM, Kalichman SC, Sileo KM, Menzies NA, Naigino R, Lin CD, Bateganya MH, Lule H, Wanyenze RK. Efficacy of an enhanced linkage to HIV care intervention at improving linkage to HIV care and achieving viral suppression following home-based HIV testing in rural Uganda: study protocol for the Ekkubo/PATH cluster randomized controlled trial. BMC Infect Dis. 2017 07 03; 17(1):460. PMID: 28673251.
    Citations: 3     Fields:    Translation:Humans
  66. Menzies NA, Soeteman DI, Pandya A, Kim JJ. Bayesian Methods for Calibrating Health Policy Models: A Tutorial. Pharmacoeconomics. 2017 Jun; 35(6):613-624. PMID: 28247184.
    Citations: 15     Fields:    Translation:Humans
  67. Rönn MM, Wolf EE, Chesson H, Menzies NA, Galer K, Gorwitz R, Gift T, Hsu K, Salomon JA. The Use of Mathematical Models of Chlamydia Transmission to Address Public Health Policy Questions: A Systematic Review. Sex Transm Dis. 2017 05; 44(5):278-283. PMID: 28407643.
    Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
  68. Soeteman DI, Menzies NA, Pandya A. Would a Large tPA Trial for Those 4.5 to 6.0 Hours from Stroke Onset Be Good Value for Information? Value Health. 2017 Jul - Aug; 20(7):894-901. PMID: 28712618.
    Citations: 1     Fields:    Translation:Humans
  69. Menzies NA, Gomez GB, Vassall A. Modelling approaches for tuberculosis: are they realistic? - Authors' reply. Lancet Glob Health. 2017 03; 5(3):e269. PMID: 28193392.
    Citations:    Fields:    Translation:Humans
  70. Isanaka S, Menzies NA, Sayyad J, Ayoola M, Grais RF, Doyon S. Cost analysis of the treatment of severe acute malnutrition in West Africa. Matern Child Nutr. 2017 10; 13(4). PMID: 27921381.
    Citations: 7     Fields:    Translation:Humans
  71. Houben RMGJ, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, Lin HH, Wu CY, Mandal S, Pandey S, Suen SC, Bendavid E, Azman AS, Dowdy DW, Bacaër N, Rhines AS, Feldman MW, Handel A, Whalen CC, Chang ST, Wagner BG, Eckhoff PA, Trauer JM, Denholm JT, McBryde ES, Cohen T, Salomon JA, Pretorius C, Lalli M, Eaton JW, Boccia D, Hosseini M, Gomez GB, Sahu S, Daniels C, Ditiu L, Chin DP, Wang L, Chadha VK, Rade K, Dewan P, Hippner P, Charalambous S, Grant AD, Churchyard G, Pillay Y, Mametja LD, Kimerling ME, Vassall A, White RG. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. Lancet Glob Health. 2016 11; 4(11):e806-e815. PMID: 27720688.
    Citations: 54     Fields:    Translation:HumansPHPublic Health
  72. Menzies NA, Gomez GB, Bozzani F, Chatterjee S, Foster N, Baena IG, Laurence YV, Qiang S, Siroka A, Sweeney S, Verguet S, Arinaminpathy N, Azman AS, Bendavid E, Chang ST, Cohen T, Denholm JT, Dowdy DW, Eckhoff PA, Goldhaber-Fiebert JD, Handel A, Huynh GH, Lalli M, Lin HH, Mandal S, McBryde ES, Pandey S, Salomon JA, Suen SC, Sumner T, Trauer JM, Wagner BG, Whalen CC, Wu CY, Boccia D, Chadha VK, Charalambous S, Chin DP, Churchyard G, Daniels C, Dewan P, Ditiu L, Eaton JW, Grant AD, Hippner P, Hosseini M, Mametja D, Pretorius C, Pillay Y, Rade K, Sahu S, Wang L, Houben RMGJ, Kimerling ME, White RG, Vassall A. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. Lancet Glob Health. 2016 11; 4(11):e816-e826. PMID: 27720689.
    Citations: 38     Fields:    Translation:Humans
  73. Chindelevitch L, Menzies NA, Pretorius C, Stover J, Salomon JA, Cohen T. Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis. J R Soc Interface. 2015 May 06; 12(106). PMID: 25878131.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  74. Menzies NA. An Efficient Estimator for the Expected Value of Sample Information. Med Decis Making. 2016 Apr; 36(3):308-20. PMID: 25911600.
    Citations: 10     Fields:    Translation:Humans
  75. Menzies NA, Cohen T, Murray M, Salomon JA. Effect of empirical treatment on outcomes of clinical trials of diagnostic assays for tuberculosis. Lancet Infect Dis. 2015 Jan; 15(1):16-7. PMID: 25541164.
    Citations: 7     Fields:    Translation:HumansCells
  76. Dowdy DW, Houben R, Cohen T, Pai M, Cobelens F, Vassall A, Menzies NA, Gomez GB, Langley I, Squire SB, White R. Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling. Int J Tuberc Lung Dis. 2014 Sep; 18(9):1012-8. PMID: 25189546.
    Citations: 5     Fields:    Translation:Humans
  77. Hallett TB, Eaton JW, Menzies N. Beware of using invalid transmission models to guide HIV health policy - authors' reply. Lancet Glob Health. 2014 May; 2(5):e261. PMID: 25103163.
    Citations:    Fields:    Translation:Humans
  78. Hallett TB, Menzies NA, Revill P, Keebler D, Bórquez A, McRobie E, Eaton JW. Using modeling to inform international guidelines for antiretroviral treatment. AIDS. 2014 Jan; 28 Suppl 1:S1-4. PMID: 24468942.
    Citations: 8     Fields:    Translation:Humans
  79. Pretorius C, Menzies NA, Chindelevitch L, Cohen T, Cori A, Eaton JW, Fraser C, Gopalappa C, Hallett TB, Salomon JA, Stover J, White RG, Dodd PJ. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models. AIDS. 2014 Jan; 28 Suppl 1:S25-34. PMID: 24468944.
    Citations: 24     Fields:    Translation:HumansPHPublic Health
  80. Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health. 2014 Jan; 2(1):e23-34. PMID: 25104632.
    Citations: 77     Fields:    Translation:Humans
  81. Keebler D, Revill P, Braithwaite S, Phillips A, Blaser N, Borquez A, Cambiano V, Ciaranello A, Estill J, Gray R, Hill A, Keiser O, Kessler J, Menzies NA, Nucifora KA, Vizcaya LS, Walker S, Welte A, Easterbrook P, Doherty M, Hirnschall G, Hallett TB. Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models. Lancet Glob Health. 2014 Jan; 2(1):e35-43. PMID: 25104633.
    Citations: 25     Fields:    Translation:Humans
  82. Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health. 2013 Dec 10; 2(1):23-34. PMID: 25083415.
    Citations: 11     Fields:    
  83. Menzies NA, Cohen T, Lin HH, Murray M, Salomon JA. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLoS Med. 2012; 9(11):e1001347. PMID: 23185139.
    Citations: 96     Fields:    Translation:HumansCells
  84. Menzies NA, Berruti AA, Blandford JM. The determinants of HIV treatment costs in resource limited settings. PLoS One. 2012; 7(11):e48726. PMID: 23144946.
    Citations: 30     Fields:    Translation:Humans
  85. Menzies NA, Berruti AA, Berzon R, Filler S, Ferris R, Ellerbrock TV, Blandford JM. The cost of providing comprehensive HIV treatment in PEPFAR-supported programs. AIDS. 2011 Sep 10; 25(14):1753-60. PMID: 21412127.
    Citations: 70     Fields:    Translation:HumansCells
  86. Menzies NA, Salomon JA. Non-monotonicity in the episodic random utility model. Health Econ. 2011 Dec; 20(12):1523-31. PMID: 22025393.
    Citations: 2     Fields:    Translation:Humans
  87. Menzies NA, Homsy J, Chang Pitter JY, Pitter C, Mermin J, Downing R, Finkbeiner T, Obonyo J, Kekitiinwa A, Tappero J, Blandford JM. Cost-effectiveness of routine rapid human immunodeficiency virus antibody testing before DNA-PCR testing for early diagnosis of infants in resource-limited settings. Pediatr Infect Dis J. 2009 Sep; 28(9):819-25. PMID: 20050391.
    Citations: 9     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Menzies's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (234)
Explore
_
Co-Authors (25)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.